SFL’s CEO Shayesteh Fürst-Ladani and SFL’s Head of Regulatory Affairs Anja Bührer, will present two free webinars on the topic “How to obtain drug regulatory approval in Europe” (12 May 2020, 6 to 7pm CEST & 14 May 2020, 9 to 10am CEST). Thomas Nirnberger, Manager International Markets at Basel Area Business & Innovation will moderate the webinar and Q&A session. The webinars will provide an overview of key aspects of drug regulatory approval including the EU centralized and decentralized approval processes, priority and fast-track procedures and criteria, the evaluation process, and EU and national incentives and support for innovation and development.

SFL will join with Basel Area Business & Innovation in hosting these webinars, which will also highlight the businesses and innovation benefits for healthcare companies who establish their EU operations in the Pharma and Life Sciences hub of the Basel Area.

Register now (12 May 2020 or 14 May 2020) to take advantage of the expert insights provided by the SFL team on this important topic and find out how EU Orphan Drug Designation could benefit your products.

SFL is highly experienced in regulatory submissions, providing both strategic and operational support for projects covering all life-cycle stages from early development to regulatory maintenance and market access/reimbursement of approved healthcare products, utilizing its unique combination of in-house expertise and a multi-disciplinary approach.